Want to see TSE:WELL full AI Analyst Report?
WELL Stock Chart & Stats
C$3.96
C$0.03(0.76%)
At close: 4:00 PM EDT
C$3.96
C$0.03(0.76%)
Day’s Range― - ―
52-Week RangeC$3.58 - C$6.08
Previous CloseN/A
Volume795.53K
Average Volume (3M)1.37M
Market Cap
C$1.07B
Enterprise ValueC$2.05K
Total Cash (Recent Filing)C$130.64M
Total Debt (Recent Filing)C$828.25M
Price to Earnings (P/E)179.1
Beta1.41
Next Earnings
Nov 05, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding255,947,020
10 Day Avg. Volume1,712,971
30 Day Avg. Volume1,366,290
Financial Highlights & Ratios
PEG Ratio1.08
Price to Book (P/B)7.73
Price to Sales (P/S)4.77
P/FCF Ratio75.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$7.30Price Target Upside84.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.23
Revenue Forecast (FY)C$1.60B
Bulls Say, Bears Say
Bulls Say
Recurring & Diversified RevenueWELL’s hybrid model blends clinic-based patient revenue with subscription and service-based technology fees, creating recurring cash streams and cross‑sell opportunities. This diversification supports predictable revenue, higher retention from embedded EMR integrations, and durable unit economics versus pure-play care or software peers.
Consistent Cash GenerationSustained positive operating and free cash flow provides internal funding for clinic upgrades, targeted acquisitions, and debt servicing. Even with recent FCF variability, multiyear cash generation capacity reduces reliance on equity raises and enables management to prioritize higher‑margin Canadian growth and gradual balance‑sheet repair.
Scale & Operational MilestonesAchieving the WELL Canada CAD100M EBITDA run rate early signals scalable clinic economics and margin leverage from network effects. The enlarged clinic footprint and provider base improve provider productivity, bargaining power for diagnostics/capex, and position WELL to convert incremental visits into sustainable adjusted EBITDA growth over several years.
Bears Say
Rising LeverageIncreased leverage from acquisition funding and credit draws raises interest and refinancing risk, limiting financial flexibility. Higher debt amplifies sensitivity to margin variability and constrains optionality for future M&A or shareholder returns until free cash flow conversion and net debt levels are meaningfully improved.
Volatile ProfitabilityModest operating margins and swings in adjusted net income reflect sensitivity to one‑time items, timing/deferrals and integration costs. This volatility weakens earnings quality and makes multi‑period planning harder, raising the risk that shortfalls could pressure cash flow and slow deleveraging or margin improvement programs.
Regulatory & Asset UncertaintyA Competition Bureau inquiry and unsettled U.S. asset dispositions create regulatory and execution overhangs. Potential remedies, divestitures, or protracted reviews could reduce expected synergies, consume management bandwidth, and delay value realization from international assets, impacting medium‑term profitability and capital allocation.
WELL Health Technologies Corp News
WELL FAQ
What was WELL Health Technologies Corp’s price range in the past 12 months?
WELL Health Technologies Corp lowest stock price was C$3.58 and its highest was C$6.08 in the past 12 months.
What is WELL Health Technologies Corp’s market cap?
WELL Health Technologies Corp’s market cap is C$1.07B.
When is WELL Health Technologies Corp’s upcoming earnings report date?
WELL Health Technologies Corp’s upcoming earnings report date is Nov 05, 2026 which is in 84 days.
How were WELL Health Technologies Corp’s earnings last quarter?
WELL Health Technologies Corp released its earnings results on Aug 06, 2026. The company reported C$0.04 earnings per share for the quarter, missing the consensus estimate of C$0.045 by -C$0.005.
Is WELL Health Technologies Corp overvalued?
According to Wall Street analysts WELL Health Technologies Corp’s price is currently Undervalued.
Does WELL Health Technologies Corp pay dividends?
WELL Health Technologies Corp does not currently pay dividends.
What is WELL Health Technologies Corp’s EPS estimate?
WELL Health Technologies Corp’s EPS estimate is 0.05.
How many shares outstanding does WELL Health Technologies Corp have?
WELL Health Technologies Corp has 255,947,020 shares outstanding.
What happened to WELL Health Technologies Corp’s price movement after its last earnings report?
WELL Health Technologies Corp reported an EPS of C$0.04 in its last earnings report, missing expectations of C$0.045. Following the earnings report the stock price went up 3.491%.
Which hedge fund is a major shareholder of WELL Health Technologies Corp?
Currently, no hedge funds are holding shares in TSE:WELL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
WELL Health Technologies Corp Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$7.30 (84.34% Upside)
C$7.30 (84.34% Upside)
Blogger Sentiment
Neutral
TSE:WELL Sentiment 50%
Sector Average 61%
Sector Average 61%
Insider Transactions
Sold Shares
Worth C$76.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.4%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.07%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.74%
Trailing 12-Months
Company Description
WELL Health Technologies Corp
WELL Health Technologies Corp. is a leading digital healthcare company with operations in Canada, the United States, and internationally, primarily supporting medical professionals. The company delivers a full spectrum of patient services through various channels. These encompass general primary care; rehabilitative therapies such as physiotherapy, occupational therapy, and chiropractic services; dietary and mental health counselling; and sleep-related treatments. Furthermore, they provide specialized medical attention from gastroenterologists, a wide array of diagnostic services including cardiology, women's health, bone/muscle health, and cancer screening, alongside comprehensive telehealth options. Beyond direct patient care, WELL Health equips practitioners with a suite of technological solutions. This portfolio includes the OSCAR Pro electronic medical record (EMR) system, several virtual health platforms like Tia Health and Circle Medical, and Apps.health, a dedicated marketplace for digital health applications. They also offer Insig for virtual care and patient engagement, revenue cycle management solutions encompassing outsourced billing, and advanced cybersecurity with patient data privacy safeguards. As of December 31, 2021, the company operated 30 primary and executive care clinics, and provided core, specialized, and accredited diagnostic health services from 49 locations throughout Ontario. Established in 2010, the company was initially known as Wellness Lifestyles Inc. before adopting its current name in July 2018. WELL Health Technologies Corp. is headquartered in Vancouver, Canada.
WELL Stock 12 Month Forecast
Average Price Target
C$7.30
▲(84.34% Upside)